Pharmaceutical pedigree anti-counterfeiting proposals (S959/HR 1919) Funding for rare disease research Deficit reduction/impact of sequestration on FDA and NIH; Food and Drug Administration Safety Over Sequestration Act of 2013 
(HR 2725); FDA User Fee Protection Act (S 1413) 340B Drug Pricing Program; Critical Care; Critical Care Assessment and Improvement Act of 2013 (HR 2651). Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
MAN - Manufacturing MED - Medical/Disease Research/Clinical Labs BUD - Budget/Appropriations HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
IKARIA
53 Frontage Road, Third Floor, Hampton, NJ, 08827-9001, US
ANNE ELIZABETH ESPOSITO ANNE ELIZABETH ESPOSITO LEAH DUFFY SVOBODA ANNE ELIZABETH ESPOSITO LEAH DUFFY SVOBODA ANNE ELIZABETH ESPOSITO LEAH DUFFY SVOBODA ANNE ELIZABETH ESPOSITO LEAH DUFFY SVOBODA